[Skip to Content]
[Skip to Content Landing]
Views 350
Citations 0
Comment & Response
March 2016

Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ

Kimberly J. Van Zee, MD1; Andrea V. Barrio, MD1; Julia Tchou, MD2; et al for the Society of Surgical Oncology Breast Disease Site Work Group
Author Affiliations
  • 1Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  • 2Rena Rowan Breast Center, Abramson Cancer Center, Division of Endocrine and Oncologic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
JAMA Oncol. 2016;2(3):397-398. doi:10.1001/jamaoncol.2015.4860

To the Editor The recent article by Narod and colleagues1 and editorial by Esserman and Yau2 have received much attention in the press, often with contradictory interpretations. This has caused confusion in the public and even among medical professionals.

First Page Preview View Large
First page PDF preview
First page PDF preview
×